COMP <GO>
DFTX vs MO // NET PROFIT MARGIN
Definium Therapeutics Inc. (NASDAQ) VS. Altria Group Inc. (NYSE) • 15-METRIC TALLY: DFTX 3
— MO 9
▲ NET PROFIT MARGIN LEADER: MO
LAST: $36.33 (-4.29%) • MKT CAP: $5.10B
net-margins
-12.90%
LAST: $78.03 (+1.67%) • MKT CAP: $128.15B
net-margins
29.80%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DFTX VS. MO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DFTX | MO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 62.50% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -32.20% | 48.40% | -80.60 | MO | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 14.7x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -3.84% | 7.08% | -10.92 | MO | /fcf-yield <GO> |
| Operating Margin | -11.60% | 42.50% | -54.10 | MO | /operating-margins <GO> |
| Net Profit Margin ACTIVE | -12.90% | 29.80% | -42.70 | MO | /net-margins <GO> |
| Revenue Growth (YoY) | 5.50% | -3.10% | +8.60 | DFTX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 5.43% | -5.43 | MO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 4.90 | +21.10 | DFTX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 6/9 | -1.00 | MO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.4 | 63.7 | -8.30 | MO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 0.92 | +0.16 | DFTX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 33.0x | 17.1x | +15.90 | MO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.10B | $128.15B | -$123.05B | MO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DFTX REV | MO REV | DFTX GROSS % | MO GROSS % | DFTX FCF | MO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $23.28B | — | 62.5% | -$131.6M | $9.07B |
| FY 2024 | $0 | $24.02B | — | 59.8% | -$79.1M | $8.61B |
| FY 2023 | $0 | $24.48B | — | — | -$64.4M | $8.19B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DFTX // BETA 1.08
MO // BETA 0.92